FDA Requests Clinical Trials to Test Asthma Drugs Symbicort, Advair – DrugWatch.com

FDA Requests Clinical Trials to Test Asthma Drugs Symbicort, Advair
DrugWatch.com
On April 15, the Food and Drug Administration (FDA) announced that the drug makers of the popular asthma medications Symbicort, Advair Diskus, Dulera and Foradil will be required to conduct clinical trials to test the medications.
FDA orders safety studies for some asthma drugsReuters
FDA Drug Safety Communication: FDA requires post-market safety trials for Long Bioscience Technology

all 12 news articles »

View full post on asthma – Google News

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.